Company / Return on Assets (ROA)
Trevi Therapeutics, Inc. Return on Assets (ROA) History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-43.2%
FY2024
5-year range
-88.2% / -23.7%
FY2020-FY2024
Trend
-32.9%
vs FY2023
Sector context
#165 of 213
Health Care
What the data says
Trevi Therapeutics, Inc.'s return on assets (roa) of -43.2% is lower than 77% of companies in the Health Care sector (FY2024). Return on Assets (ROA) has fluctuated over the past 7 years, ranging from -195.2% in FY2018 to -23.7% in FY2022.
Based on SEC 10-K filings.
-43.2% in FY2024 with a 5-year CAGR of +0.2%.
Declined from -23.7% to -43.2% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +45.0pp
- 5-Year Change
- +0.2pp
- 10-Year Change
- -
Sector benchmark
-79.0% below sector average
Key checks
Key Insights
- In FY2024, return on assets (roa) decreased 32.9% year-over-year.
- Currently 19.1pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2022.
- Lowest return on assets (roa) in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -43.2% | -32.9% |
| FY2023 | -32.5% | -37.2% |
| FY2022 | -23.7% | +73.1% |
| FY2021 | -88.2% | -26.9% |
| FY2020 | -69.5% | -60.1% |
| FY2019 | -43.4% | +77.8% |
| FY2018 | -195.2% | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026